Peter A Singer’s research while affiliated with University of Toronto and other places

What is this page?


This page lists works of an author who doesn't have a ResearchGate profile or hasn't added the works to their profile yet. It is automatically generated from public (personal) data to further our legitimate goal of comprehensive and accurate scientific recordkeeping. If you are this author and want this page removed, please let us know.

Publications (365)


‘Mind the gap’: science and ethics in nanotechnology
  • Chapter

July 2020

·

33 Reads

·

5 Citations

Anisa Mnyusiwalla

·

·

Peter A Singer



Grand challenges in humanitarian aid

July 2018

·

120 Reads

·

23 Citations

Nature

Fund and study these priorities for natural and social sciences to meet a gaping need, urge Abdallah S. Daar, Trillium Chang, Angela Salomon and Peter A. Singer. Fund and study these priorities for natural and social sciences to meet a gaping need.


Addressing Ethical, Social, and Cultural Issues in Global Health Research
  • Literature Review
  • Full-text available

August 2013

·

397 Reads

·

19 Citations

Summary The purpose of this paper is to encourage reflection among the global health research community and the research ethics community about how a wide range of ethical, social, and cultural (ESC) influences on the conduct, success, and impact of global health research can best be addressed by consultation services in research ethics (CSRE). We draw on lessons we have learned during our experiences with the ESC Program of the Grand Challenges in Global Health initiative to propose key features of CSRE that may prove useful for those designing or implementing similar programs.

Download


Table 1 Key R&D, publication, patenting, and pharmaceutical market indicators for China, India, Brazil, South Africa and select developed markets
Table 2 Health biotech firms from China, India, Brazil and South Africa included for this analysis
Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators

June 2012

·

500 Reads

·

57 Citations

Health Research Policy and Systems

Biopharmaceutical innovation has had a profound health and economic impact globally. Developed countries have traditionally been the source of most innovations as well as the destination for the resulting economic and health benefits. As a result, most prior research on this sector has focused on developed countries. This paper seeks to fill the gap in research on emerging markets by analyzing factors that influence innovative activity in the indigenous biopharmaceutical sectors of China, India, Brazil, and South Africa. Using qualitative research methodologies, this paper a) shows how biopharmaceutical innovation is taking place within the entrepreneurial sectors of these emerging markets, b) identifies common challenges that indigenous entrepreneurs face, c) highlights the key role played by the state, and d) reveals that the transition to innovation by companies in the emerging markets is characterized by increased global integration. It suggests that biopharmaceutical innovators in emerging markets are capitalizing on opportunities to participate in the drug development value chain and thus developing capabilities and relationships for competing globally both with and against established companies headquartered in developed countries.


. Genomics for Universal Healthcare in Thailand1,2

May 2012

·

1 Read

One potential outcome of investing in genomic medicine is the provision of tools for creating a more cost-effective healthcare system. Partly with this aim in mind, Thailand has launched two genotyping initiatives: the Thai SNP Discovery Project and the Thai Center for Excellence in Life Sciences Pharmacogenomics Project. Together, these projects will help Thailand understand the genomic diversity of its population, and explore the role that this diversity has in drug response and disease susceptibility in its population. This chapter discusses challenges faced by Thailand to integrate genomic medicine in its relatively young universal healthcare system.




Citations (82)


... A recognition of human solidarity, our fundamental connection to other humans, demands that we aid those in need. 42 10. Health is a human right, and all people(s) are obligated to ensure the fulfillment of that right to whatever extent is possible. ...

Reference:

Contextual bias, the democratization of healthcare, and medical artificial intelligence in low‐ and middle‐income countries (full-text here: https://onlinelibrary.wiley.com/share/author/Q99IXEZZHD6BURXN6TFJ?target=10.1111/bioe.12927)
Global health ethics: the rationale for mutual caring
  • Citing Chapter
  • February 2011

... 3 Nurses who receive adequate and systematic bioethics education will be better prepared to deal with expected and unexpected ethical problems in nursing care practice. [4][5][6] For the last three decades, various efforts to teach bioethics to nurses and nursing students have been made in the United States; 7-10 however, bioethics education is not well implemented in nursing schools in Korea. In Korea, most nursing schools deal with only four principles of biomedical ethics and some relevant ethical issues, such as artificial insemination, abortion, and euthanasia in their curricula. ...

Teaching bioethics to medical students and postgraduate trainees in the clinical setting
  • Citing Chapter
  • January 2008

... The cup appears green in reflected light and red in transmitted light [4]. Research on nanoscience and nanotechnology always focusses on the ethical issues like privacy, equity, and environmental aspects [9] [10] [11]. The questions on behalf of the ethical aspects of nanotechnology arises from the knowledge of the hazards of nanomaterials and the threats faced by those who handle them [12]. ...

‘Mind the gap’: science and ethics in nanotechnology
  • Citing Chapter
  • July 2020

... 4 While EMS providers have ethical and professional duties to work, these duties have limits when doing so could put them or their family members in serious dangers. 5 Research studies demonstrate different findings regarding the attitude of healthcare workers to work during different types of disasters including disease outbreaks. [6][7][8][9][10][11][12] Studies found that man-made events and pandemics are typically the disasters to which first responders feel unfamiliar and fear, and in turn, are less willing to respond. ...

Ethics and SARS: lessons from Toronto
  • Citing Chapter
  • October 2018

... In the context of health, a Grand Challenge is defined as a critical barrier that, if removed, would help solve an important global health problem. 4 A list of climate and health challenges could help to catalyse and direct innovation in the growing and evolving climate and health sector. ...

Grand challenges in humanitarian aid
  • Citing Article
  • July 2018

Nature

... Their data did not show much change in the rate of international collaboration for the period studied, but they highlighted that countries with small science systems relied more heavily on international collaboration than countries with larger science systems. International collaboration in HBT may represent to Latin American countries opportunities to achieve their goals faster of promoting health, innovation, and competitiveness, as has been observed in other scientific fields [118,[131][132][133][134]. ...

Erratum: South-South entrepreneurial collaboration in health biotech (Nat. Biotechnol. (2010) 28 (407-416)
  • Citing Article
  • December 2010

Nature Biotechnology

... Organizational ethics in healthcare deals with the ethical aspects of the structure, organization, and control models of the healthcare system. PDs and guidelines are examined to identify how conflicting goals, values, and interests are and should be handled (Gibson et al. 2014;Emanuel 2000). A basic assumption is that the structural design of the system has-at least to some extent-been intentionally planned to achieve certain effects. ...

Organizational ethics
  • Citing Article
  • January 2008

... The following definition for an elimination investment case was used: "a body of data upon which evaluations will be based and investment commitments made when new eradication initiatives are established". 5 The proceedings from the meeting present a synthesis of the views of the NTD donors and technical experts present in the meeting. ...

Group Report: Developing an Eradication Investment Case
  • Citing Article
  • September 2011

... While such metrics are relevant to evaluating researcher expertise and history of collaboration, they may also entrench privilege and perpetuate disparities in research, where highly recognized researchers and institutions disproportionately access opportunities for further reward, while the efforts of less-well-known counterparts receive substantially less Frontiers in Education 10 frontiersin.org opportunity and reward (Lavery et al., 2013;Piper and Wellmon, 2017). The over-reliance on publication-focused metrics also obscures other meaningful types of engagement in global health research, such as through advocacy or capacity building. ...

Addressing Ethical, Social, and Cultural Issues in Global Health Research

... В частности, в 1946 г. закон США об атомной энергии установил запрет на распространение информации о ядерном оружии до формального рассекречивания. Однако, как было отмечено в научной работе П. Сингера и А. Даара о передаче технологий двойного, биотехнологии в отличие от ядерных технологий не требуют аналогичного объема инвестиций в разработку; научные знания, полученные в ходе исследований, общедоступны и не засекречены; технические средства для производства широко доступны (Singer & Daar, 2009). ...

How Biodevelopment can Enhance Biosecurity
  • Citing Article
  • March 2009

Bulletin of the Atomic Scientists